Vaccination with an adenoviral vector encoding hepatitis C virus (HCV) NS3 protein protects against infection with HCV-recombinant vaccinia virus

Author： Arribillaga L.   de Cerio A.L.D.   Sarobe P.   Casares N.   Gorraiz M.   Vales A.   Bruna-Romero O.   Borras-Cuesta F.   Paranhos-Baccala G.   Prieto J.   Ruiz J.   Lasarte J.J.  

Publisher： Elsevier

ISSN： 0264-410X

Source： Vaccine, Vol.21, Iss.3, 2002-12, pp. : 202-210

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

DNA-based vaccination against hepatitis C virus (HCV): effect of expressing different forms of HCV E2 protein and use of CpG-optimized vectors in mice

By Ma X.   Forns X.   Gutierrez R.   Mushahwar I.K.   Wu T.   Payette P.J.   Bukh J.   Purcell R.H.   Davis H.L.  

Vaccine, Vol. 20, Iss. 27, 2002-09 ,pp. : 3263-3271

Elsevier

Access to resources Recommend Favorite

Protective efficacy of vaccination by recombinant vaccinia virus against Neospora caninum infection

By Nishikawa Y.   Inoue N.   Xuan X.   Nagasawa H.   Igarashi I.   Fujisaki K.   Otsuka H.   Mikami T.  

Vaccine, Vol. 19, Iss. 11, 2001-12 ,pp. : 1381-1390

Elsevier

Access to resources Recommend Favorite

Immunization with recombinant Calmette-Guerin bacillus (BCG)-hepatitis C virus (HCV) elicits HCV-specific cytotoxic T lymphocytes in mice

By Uno-Furuta S.   Matsuo K.   Tamaki S.   Takamura S.   Kamei A.   Kuromatsu I.   Kaito M.   Matsuura Y.   Miyamura T.   Adachi Y.   Yasutomi Y.  

Vaccine, Vol. 21, Iss. 23, 2003-07 ,pp. : 3149-3156

Elsevier

Access to resources Recommend Favorite

Development of a replication-deficient recombinant vaccinia virus vaccine effective against parainfluenza virus 3 infection in an animal model

By Wyatt L.S.   Shors S.T.   Murphy B.R.   Moss B.  

Vaccine, Vol. 14, Iss. 15, 1996-10 ,pp. : 1451-1458

Elsevier

Access to resources Recommend Favorite

A single immunization with a plasmid encoding hepatitis C virus (HCV) structural proteins under the elongation factor 1- promoter elicits HCV-specific cytotoxic T-lymphocytes (CTL)

By Nishimura Y.   Kamei A.   Uno-Furuta S.   Tamaki S.   Kim G.   Adachi Y.   Kuribayashi K.   Matsuura Y.   Miyamura T.   Yasutomi Y.  

Vaccine, Vol. 18, Iss. 7, 1999-11 ,pp. : 675-680

Elsevier

Access to resources Recommend Favorite